A randomised, double blind, parallel-group study of the oxidative stress lowering effect of simvastatin and atorvastatin

Trial Profile

A randomised, double blind, parallel-group study of the oxidative stress lowering effect of simvastatin and atorvastatin

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Atorvastatin (Primary) ; Simvastatin
  • Indications Hyperlipidaemia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 09 Jun 2008 Status changed from initiated to recruiting as reported by ClinicalTrials.gov.
    • 09 Jun 2008 The expected completion date for this trial is now 1 Jul 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top